Alexion Pharmaceuticals
ULTOMIRIS
Manufacturer:
Alexion Pharmaceuticals
Name:
ULTOMIRIS
HCPCS Code Descriptor:
Injection, ravulizumab-cwvz, 10 mg
Category:
J Code
HCPCS:
J1303
NDC(s):
25682-0025-01, 25682-0028-01
Primary Type:
Immunology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ULTOMIRIS is an Immunology drug manufactured by Alexion Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J1303 is aligned to the drug ULTOMIRIS.
Ultomiris is belongs to a class of drugs known as monoclonal antibodies. This drug works by inhibiting the C5 protein in the terminal complement cascade of the patient’s immune system. Ultomiris is a branded drug manufactured by Alexion Pharmaceuticals. Prior to its J Code assignment (J1303) in October 2019, Ultomiris was aligned to the C Code: C9052. Patient assistance programs can for Ultomiris can be found through Alexion’s OneSource.